Nevertheless, it has been shown that dual immunoproteasome inhibition (LMP7/LMP2 or LMP7/MECL-1) is required to be effective in modifying cytokine secretion, the amelioration of autoimmunity, and Th17 differentiation [58,59]. This evidence concerns the gene PSMB9 and Autoimmunity.